Industry

Seagen Announces Results from Pivotal MOUNTAINEER Trial Demonstrating Clinically Meaningful Antitumor Activity of TUKYSA® (tucatinib) in Combination with Trastuzumab in Previously Treated HER2-Positive Metastatic Colorectal Cancer

–Phase 2 trial showed chemotherapy-free TUKYSA combination resulted in clinically meaningful and durable tumor responses– –Results presented in late-breaking oral session at the ESMO World Congress on Gastrointestinal Cancer– BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq:SGEN) today announced full results from the pivotal phase 2 MOUNTAINEER trial, which showed TUKYSA® (tucatinib) in combination with trastuzumab was well-tolerated … [Read more…]

Scholar Rock to Present Phase 3 SAPPHIRE Trial Design at the 17th International Congress on Neuromuscular Diseases (ICNMD 2022)

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced an e-poster presentation by Thomas Crawford, M.D., on the design of the company’s ongoing SAPPHIRE Phase 3 clinical trial in spinal muscular atrophy (SMA) at … [Read more…]

2022 Good Documentation Practices Webinar – Look at Documentation Practices That Should be Avoided – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Good Documentation Practices” webinar has been added to ResearchAndMarkets.com’s offering. “Good Documentation Practices” is a “current” industry practice that is reviewed and cited by federal regulators when audited. Pharmaceutical/Biological documents are legal documents that are controlled by all regulatory agencies. The person or persons responsible for filling out these documents accepts the consequences … [Read more…]

Regulatory Affairs Outsourcing Market Report 2022: Increasing Use of Digital Platforms/Solutions in Regulatory Affairs Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Regulatory Affairs Outsourcing Market – Global Outlook and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The following factors will drive the global regulatory affairs outsourcing market growth during the forecast period: Increasing Use of Digital Platforms/Solutions in Regulatory Affairs Changing Regulatory Landscape Rising Demand For Fast Drug & Medical Device Approvals … [Read more…]

US Branded Generics Market to Reach $172.03 Million by 2027 from $77.9 Million in 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Branded Generics Market Research Report by Product (Trade Named Generics and Value-Added), Application, Distribution Channel, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Branded Generics Market size was estimated at USD 64.00 million in 2021, USD 77.90 million in … [Read more…]

New Prostatefocus Genetic Screening Test from Oncologica; Identifying Men at Increased Risk of Developing Prostate Cancer

CAMBRIDGE, England–(BUSINESS WIRE)–#DNAcancertest—Oncologica, a leading genetic cancer and viral testing laboratory based in Cambridge UK, has launched its new Prostatefocus cancer genetic screening test that identifies men at increased risk of developing prostate cancer. Prostate cancer is the most common cancer in men with 50,000 people in the UK diagnosed with the disease each year. … [Read more…]

Global Hypertrophic & Keloid Scar Treatment Market Research Report to 2027 – Players Include CCA Industries, Cynosure, Honeydew Products and HRA Pharma – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hypertrophic & Keloid Scar Treatment Market Research Report by Scar Type (Hypertrophic Scar and Keloid Scar), Product, End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Hypertrophic & Keloid Scar Treatment Market size … [Read more…]

ClexBio Announces New Appointments to Board of Directors

OSLO, Norway & BOSTON–(BUSINESS WIRE)–ClexBio, an early-stage biotech company developing next-generation tissue engineered grafts for transplant, is announcing the appointment of two new members to its Board of Directors. Joining the board with immediate effect are Andreas Lehmann as non-executive Chairman and Wasim Malik as independent Director. Armend G. Håti, Co-Founder and CEO of ClexBio, … [Read more…]

University of Phoenix College of Doctoral Studies Releases Whitepaper on Reskilling and Upskilling Workers in the Post-Pandemic Era

Insights by Dr. Mansureh Kebritchi draw on data from 2022 Career Optimism Index® study PHOENIX–(BUSINESS WIRE)–University of Phoenix College of Doctoral Studies announces the release of a new whitepaper by Mansureh Kebritchi, Ph.D., chair, Center for Educational and Instructional Technology Research (CEITR) within the College of Doctoral Studies, which draws upon data from the 2022 … [Read more…]